Altium Wealth Management LLC Vertex Pharmaceuticals Inc Transaction History

Altium Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$207.02 - $241.31 $242,006 - $282,091	-1,169 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$207.01 - $276.09 $20,079 - $26,780	97 Added 9.05%	1,169 $276,000
Q3 2020 Oct 26, 2020	BUY	$255.65 - $303.1 $6,135 - $7,274	24 Added 2.29%	1,072 $292,000
Q2 2020 Jul 31, 2020	BUY	$225.48 - $295.8 $15,332 - $20,114	68 Added 6.94%	1,048 $304,000
Q1 2020 Apr 23, 2020	BUY	$199.77 - $247.81 $195,774 - $242,853	980 New	980 $233,000

1,625

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Altium Wealth Management LLC with notifications on news.